印度和欧盟最后敲定了一项贸易协议,削减医疗物资的关税,促进药品出口。 India and the EU finalize a trade deal cutting tariffs on medical goods and boosting pharmaceutical exports.

2026年1月27日最后敲定的《印度-欧盟自由贸易协定》取消了对90%的欧洲医疗、光学和外科设备征收的关税,并降低了对药品和化学品征收的关税,增加了印度获得负担得起的药品和先进的保健技术的机会。 The India-EU Free Trade Agreement, finalized on January 27, 2026, eliminates tariffs on 90% of European medical, optical, and surgical equipment and reduces duties on pharmaceuticals and chemicals, enhancing access to affordable medicines and advanced healthcare technologies in India. 预计这项交易将促进印度对欧盟的药品出口,特别是使中小型企业受益,同时使印度的AYUSH从业人员在欧盟国家获得承认。 The deal is expected to boost Indian pharmaceutical exports to the EU, particularly benefiting small and medium-sized enterprises, while enabling Indian AYUSH practitioners to gain recognition in EU countries. 其目的是加强贸易,改善供应链一体化,促进保健、知识产权和创新方面的合作,欧盟预计到2032年印度的出口将增加一倍。 It aims to strengthen trade, improve supply chain integration, and foster collaboration in healthcare, intellectual property, and innovation, with the EU projecting a doubling of exports to India by 2032.